Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways
Risk factor
Profitability factor
Very low or no dividends
Data is available to registered users only
About
POZEN Inc. is a pharmaceutical company that develops therapeutics for diseases with unmet medical needs. The Company's product candidates includes migraine treatments as well as is exploring the development of product candidates in other pain-related therapeutic areas.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expens
Data is available to registered users only
